ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Nymox Pharmaceutical Corp (PK)

Nymox Pharmaceutical Corp (PK) (NYMXF)

0.161
-0.009
(-5.29%)
Closed July 16 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.161
Bid
0.161
Ask
0.1999
Volume
38,435
0.161 Day's Range 0.19
0.0501 52 Week Range 1.275
Market Cap
Previous Close
0.17
Open
0.161
Last Trade
100
@
0.161
Last Trade Time
Financial Volume
$ 6,598
VWAP
0.171668
Average Volume (3m)
18,162
Shares Outstanding
90,520,000
Dividend Yield
-
PE Ratio
-2.75
Earnings Per Share (EPS)
-0.07
Revenue
-
Net Profit
-6.58M

About Nymox Pharmaceutical Corp (PK)

Sector
Chemicals & Chem Preps, Nec
Industry
Chemicals & Chem Preps, Nec
Website
Headquarters
Nassau, Bhs
Founded
1970
Nymox Pharmaceutical Corp (PK) is listed in the Chemicals & Chem Preps sector of the OTCMarkets with ticker NYMXF. The last closing price for Nymox Pharmaceutical (PK) was $0.17. Over the last year, Nymox Pharmaceutical (PK) shares have traded in a share price range of $ 0.0501 to $ 1.275.

Nymox Pharmaceutical (PK) currently has 90,520,000 shares outstanding. The market capitalization of Nymox Pharmaceutical (PK) is $15.39 million. Nymox Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of -2.75.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01056.976744186050.15050.2450.1505154390.18247953CS
40.04134.16666666670.120.289950.12162810.17757552CS
12-0.124-43.50877192980.2850.349920.0501181620.20404571CS
26-0.279-63.40909090910.440.550.0501195660.30581526CS
52-0.2641-62.12655845680.42511.2750.0501445900.76416968CS
1560.04134.16666666670.121.2750.0501494310.73052608CS
2600.04134.16666666670.121.2750.0501494310.73052608CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SHIMShimmick Corporation
$ 3.13
(51.21%)
3.11M
AFARAura FAT Projects Acquisition Corporation
$ 16.80
(34.40%)
50.33k
AFARUAura FAT Projects Acquisition Corporation
$ 16.50
(33.82%)
1.73k
AEHRAehr Test Systems
$ 18.91
(12.29%)
1.84M
ASSTAsset Entities Inc
$ 1.7617
(12.21%)
629.65k
RNLXRenalytix PLC
$ 0.308
(-10.44%)
26.62k
SHPWShapeways Holdings Inc
$ 0.2699
(-10.03%)
102.96k
PETWag Group Company
$ 1.40
(-9.68%)
61.9k
FIVEFive Below Inc
$ 92.47
(-9.41%)
588.33k
LVTXLAVA Therapeutics NV
$ 1.92
(-9.00%)
2.39k
MAXNMaxeon Solar Technologies Ltd
$ 0.2388
(-5.39%)
16.67M
TKLFYoshitsu Company Ltd
$ 0.6279
(0.79%)
9.04M
AGRIAgriFORCE Growing Systems Ltd
$ 0.0813
(-5.68%)
7.79M
SILOSilo Pharma Inc
$ 2.33
(-2.51%)
4.68M
SIRISirius XM Holdings Inc
$ 3.85
(-0.77%)
4.03M

NYMXF Discussion

View Posts
Renee Renee 1 year ago
NYMX changed to NYMXF. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Picked up some
πŸ‘οΈ0
Spicknspan Spicknspan 1 year ago
A one time injectable treatment for an enlarged prostate would have a huge market. Bought a few here so I know I will keep an eye on the news.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
NDA not coming soon?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
NDA Coming soon?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Up today on NO news?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Delays and more delays and now more dilution. $.50 coming soon.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Will NYMX file NDA by 9/15/21?
πŸ‘οΈ0
lytnup lytnup 3 years ago
Less than a month away.

Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the β€œCompany”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."

https://nymox.com/files/download/45b2b195922068b
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
2ND QUARTER RESULTS DISSAPOINTING AS USUAL. STILL NO UPDATES ON NDA.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
NDA appication coming soon? I have my doubts.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Now what?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Director - James G Robinson just picked up 38,000 shares. This was his first purchase in over a 1 1/2 years and he now owns 3,550,550 shares. He has done this many times and usually buys when it drops to around $2 or less. He is 85 years old now and God Bless he lives long enough to see this drug get FDA approval and come to market.
πŸ‘οΈ0
stillchillin stillchillin 3 years ago
Who is buying today?? Is it GR loading up in front of good news? He has a boat load and has been holding for a while
πŸ‘οΈ0
wesley_ wesley_ 3 years ago
$2.48 picked some up
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Good news or bad? The clock is ticking!
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
Going down down down down down!
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
ANOTHER NICE DAY!
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 3 years ago
BIG NEWS COMING IN Q1.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Yawn
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
NDA - Ist quarter 2021, could it finally happen?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Big news coming soon?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
The year is almost over and still no significant news!
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
What is taking so long???
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
NDA NDA NDA NDA ?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Even more dilution???
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
NEWS TODAY. GOOD, BAD OR SAME OLD SAME OLD.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
More dilution - $12,000,000 stock offering.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82880626/prospectus-filed-pursuant-to-rule-424b5-424b5
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Starting to turn Bearish on this.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Will NYMX ever succeed?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
NDA ?? I will believe it when I see it.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Dog and pony show continues.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Tick Tick Tick....
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Hopefully good news coming soon.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
What's the holdup?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
$12,000,000. STOCK OFFERING.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82306706/securities-registration-foreign-private-issuer-f-3
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Even the Coronavirus can't keep NYMX down.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Hope this drops under $2, I will stock up.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Lots of news lately. Hoping for the NDA soon.
πŸ‘οΈ0
tayronachan tayronachan 4 years ago
But will they have anything to offer in helping stop the new corona virus, or helping the victims?
Any of this?..........."The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development. Nymox maintains an active interest in scientific collaborations and has a lengthy history of working together with prominent researchers around the world."
πŸ‘οΈ0
zumantu zumantu 4 years ago
Boom?
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 4 years ago
Tick, tick, tick, tick.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Report...
πŸ‘οΈ0
yankees18 yankees18 5 years ago
Took some
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
Happy New Year for NYMX.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
Fraud, Failure or Look for NDA in 2020
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
As at November 15, 2019, 69,968,706 common shares without par value of the Corporation were outstanding.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
RESULTS FORTHCOMING.
πŸ‘οΈ0
Suds Mackenzie Suds Mackenzie 5 years ago
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
πŸ‘οΈ0
zumantu zumantu 5 years ago
Did I miss the big news?
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock